| Mr James Travis Gillham, R,PH | |
|
9350 Marshall Dr, Lenexa, KS 66215-3845 | |
| (913) 227-3702 | |
| (913) 227-3722 |
| Full Name | Mr James Travis Gillham |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 9350 Marshall Dr, Lenexa, Kansas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1336422690 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 13431 (Kansas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mr James Travis Gillham, R,PH 9350 Marshall Dr, Lenexa, KS 66215-3845 Ph: (913) 227-3702 | Mr James Travis Gillham, R,PH 9350 Marshall Dr, Lenexa, KS 66215-3845 Ph: (913) 227-3702 |
News Archive
Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, announces that data from its Phase 2 PV-10 metastatic melanoma study will be presented at two upcoming melanoma conferences.
A targeted drug has shown promising activity against brain metastases resulting from kidney cancer, achieving a 50 percent response rate, and supporting further studies of the drug in this patient group whose poor prognosis has created a significant unmet need.
New clinical data showed an experimental drug called pertuzumab prolonged the survival time for women with recurrent ovarian cancer, a University of Alabama at Birmingham doctor said recently.
Advanced Cell Technology, Inc. announced today that it filed an Investigational New Drug (IND) Application with the US Food and Drug Administration (FDA) to initiate a Phase I/II multicenter study using embryonic stem cell derived retinal cells to treat patients with Stargardt's Macular Dystrophy (SMD). Among the most common causes of untreatable blindness in the world are degenerative diseases of the retina.
Teva Pharmaceutical Industries Ltd and Barr Pharmaceuticals, Inc. announced today that they have signed a definitive agreement under which Teva will acquire Barr, the fourth largest generic drug company worldwide.
› Verified 3 days ago
Jacob Thomas Stolz, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 15100 W 87th Street Pkwy, Lenexa, KS 66219 Phone: 913-438-5172 | |
Katy Dolinar, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 13400 W 87th Street Pkwy, Lenexa, KS 66215 Phone: 913-438-6651 | |
Christopher Shane Slifer, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 11131 W 79th St, Lenexa, KS 66214 Phone: 913-234-4664 Fax: 913-234-4665 | |
Jill Ann Ottinger, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 11131 W 79th St, Lenexa, KS 66214 Phone: 913-234-4664 | |
Jerald E. Bowmer, R.PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 17301 W 84th Ter, Lenexa, KS 66219 Phone: 913-530-1493 Fax: 913-599-5435 | |
Ms. Elaine Carol Clancy, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 11162 Renner Blvd, Lenexa, KS 66219 Phone: 800-360-0520 | |
Jonathan Fernandez, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 10050 Woodland Dr, Lenexa, KS 66220 Phone: 913-397-0906 Fax: 913-397-0332 |